These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
175 related items for PubMed ID: 30830647
1. Perspectives of Hospital Pharmacists Towards Biosimilar Medicines: A Survey of Polish Pharmacy Practice in General Hospitals. Pawłowska I, Pawłowski L, Krzyżaniak N, Kocić I. BioDrugs; 2019 Apr; 33(2):183-191. PubMed ID: 30830647 [Abstract] [Full Text] [Related]
2. The growing role of biologics and biosimilars in the United States: Perspectives from the APhA Biologics and Biosimilars Stakeholder Conference. Crespi-Lofton J, Skelton JB. J Am Pharm Assoc (2003); 2017 Apr; 57(5):e15-e27. PubMed ID: 28689708 [Abstract] [Full Text] [Related]
3. Assessing awareness and attitudes of healthcare professionals on the use of biosimilar medicines: A survey of physicians and pharmacists in Ireland. O'Callaghan J, Bermingham M, Leonard M, Hallinan F, Morris JM, Moore U, Griffin BT. Regul Toxicol Pharmacol; 2017 Aug; 88():252-261. PubMed ID: 28666961 [Abstract] [Full Text] [Related]
4. A survey of global biosimilar implementation practice conducted by the International Society of Oncology Pharmacy Practitioners. Foreman E, Patel H, Siderov J, Harchowal J, Bubalo J, Chan A. J Oncol Pharm Pract; 2020 Apr; 26(3_suppl):22-32. PubMed ID: 32268828 [Abstract] [Full Text] [Related]
5. Knowledge, behaviors and practices of community and hospital pharmacists towards biosimilar medicines: Results of a French web-based survey. Beck M, Michel B, Rybarczyk-Vigouret MC, Levêque D, Sordet C, Sibilia J, Velten M. MAbs; 2017 Apr; 9(2):383-390. PubMed ID: 27929743 [Abstract] [Full Text] [Related]
6. Malaysian Hospital Pharmacists' Perspectives and Their Role in Promoting Biosimilar Prescribing: A Nationwide Survey. Mohd Sani N, Aziz Z, Kamarulzaman A. BioDrugs; 2023 Jan; 37(1):109-120. PubMed ID: 36571697 [Abstract] [Full Text] [Related]
7. Pharmacists' Perspectives of Biosimilars: A Systematic Review. Mohd Sani N, Aziz Z, Panickar R, Kamarulzaman A. BioDrugs; 2022 Jul; 36(4):489-508. PubMed ID: 35776294 [Abstract] [Full Text] [Related]
8. Knowledge and perception of biosimilars in ambulatory care: a survey among Belgian community pharmacists and physicians. Barbier L, Vandenplas Y, Simoens S, Declerck P, Vulto AG, Huys I. J Pharm Policy Pract; 2021 Jun 22; 14(1):53. PubMed ID: 34158128 [Abstract] [Full Text] [Related]
9. Assessment of pharmacists' views on biosimilar naming conventions. Fernandez-Lopez S, Kazzaz D, Bashir M, McLaughlin T. J Manag Care Spec Pharm; 2015 Mar 22; 21(3):188-95. PubMed ID: 25726028 [Abstract] [Full Text] [Related]
10. Pharmacist biosimilar survey reveals knowledge gaps. Stevenson JG, McCabe D, McGrath M, McBride A. J Am Pharm Assoc (2003); 2023 Mar 22; 63(2):529-537.e7. PubMed ID: 36437154 [Abstract] [Full Text] [Related]
11. Knowledge, perceptions, attitude, barriers and facilitators of biosimilars use across specialty physicians and hospital pharmacists: A national survey. Marín-Jiménez I, Carrascosa JM, Guigini MA, Monte-Boquet E. Farm Hosp; 2021 Jul 07; 45(5):240-246. PubMed ID: 34806583 [Abstract] [Full Text] [Related]
12. Understanding US Physician and Pharmacist Attitudes Toward Biosimilar Products: A Qualitative Study. Rupert DJ, Jordan AM, Ziemian MA, Brown RM, Fleming NS, Lefebvre RC. BioDrugs; 2022 Sep 07; 36(5):645-655. PubMed ID: 35962911 [Abstract] [Full Text] [Related]
13. Biosimilar Naming Conventions: Pharmacist Perceptions and Impact on Confidence in Dispensing Biologics. Tomaszewski D. J Manag Care Spec Pharm; 2016 Aug 07; 22(8):919-26. PubMed ID: 27459654 [Abstract] [Full Text] [Related]
14. Clinical and conventional pharmacy services in Polish hospitals: a national survey. Pawłowska I, Pawłowski L, Kocić I, Krzyżaniak N. Int J Clin Pharm; 2016 Apr 07; 38(2):271-9. PubMed ID: 26739130 [Abstract] [Full Text] [Related]
15. Awareness and Knowledge of Pharmacists toward Biosimilar Medicines: A Survey in Jordan. Oqal M, Hijazi B, Alqudah A, Al-Smadi A, A Almomani B, Alnajjar R, Abu Ghunaim M, Irshaid M, Husam A. Int J Clin Pract; 2022 Apr 07; 2022():8080308. PubMed ID: 35832802 [Abstract] [Full Text] [Related]
16. Position Paper from the Portuguese Association of Hospital Pharmacists for biosimilar therapeutic antibodies. Goncalves J, Matos de Brito P, Batista A, Feio J, Machado F, Aperta J, Ascensão I, Pires V, Oliveira C, Armandina Pontes R, Alcobia A, Paulo Cruz J, Lampreia Guerreiro S, Farinha H, Margarida Freitas A, Caetano M, Almeida P, Costa B, Oliveira C, Campos C, Madureira B, Cavaco M, Catarino H, other members presented at APFH meeting of biosimilar positioning on behalf of Portuguese Association of Hospital Pharmacists. J Clin Pharm Ther; 2017 Apr 07; 42(2):239-243. PubMed ID: 27859438 [Abstract] [Full Text] [Related]
17. Healthcare professionals' perceptions and perspectives on biosimilar medicines and the barriers and facilitators to their prescribing in UK: a qualitative study. Aladul MI, Fitzpatrick RW, Chapman SR. BMJ Open; 2018 Nov 18; 8(11):e023603. PubMed ID: 30455389 [Abstract] [Full Text] [Related]
18. Identifying Key Benefits in European Off-Patent Biologics and Biosimilar Markets: It is Not Only About Price! Dutta B, Huys I, Vulto AG, Simoens S. BioDrugs; 2020 Apr 18; 34(2):159-170. PubMed ID: 31792843 [Abstract] [Full Text] [Related]
19. Awareness, Knowledge, and Perceptions of Biosimilars Among Specialty Physicians. Cohen H, Beydoun D, Chien D, Lessor T, McCabe D, Muenzberg M, Popovian R, Uy J. Adv Ther; 2017 Jan 18; 33(12):2160-2172. PubMed ID: 27798772 [Abstract] [Full Text] [Related]
20. Provider and patient knowledge gaps on biosimilars: insights from surveys. Gibofsky A, Evans C, Strand V. Am J Manag Care; 2022 Nov 18; 28(12 Suppl):S227-S233. PubMed ID: 36493396 [Abstract] [Full Text] [Related] Page: [Next] [New Search]